Instil Bio, Inc. is a biotechnology company focused on identifying and advancing innovative therapeutic opportunities. Its former lead product candidate, AXN-2510, was a bispecific antibody targeting PD-L1 and the VEGF family in solid tumor cancers, in-licensed from ImmuneOnco in August 2024 but discontinued in January 2026. Prior to AXN-2510, the company pursued cell therapies, including a proprietary folate receptor alpha co-stimulatory antigen receptor (CoStAR) tumor infiltrating lymphocyte (TIL) cell therapy for cancer. The company is actively seeking to in-license or acquire additional novel therapeutic candidates in diseases with significant unmet medical need.
Q2 FY2026 — expected 2026-08-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001789769-26-000019 | EDGAR | 69K words |
| 2025-03-04 | 2024-12-31 | 0001789769-25-000017 | EDGAR | 77K words |
| 2024-03-21 | 2023-12-31 | 0001789769-24-000036 | EDGAR | 83K words |
| 2023-03-31 | 2022-12-31 | 0001789769-23-000035 | EDGAR | 88K words |
| 2022-03-07 | 2021-12-31 | 0001789769-22-000008 | EDGAR | 91K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-16 | 2026-09-30 | 0001789769-26-000067 | EDGAR | — |
| 2026-08-13 | 2026-06-30 | 0001789769-26-000057 | EDGAR | 18K words |
| 2025-11-13 | 2025-09-30 | 0001789769-25-000094 | EDGAR | 59K words |
| 2025-08-13 | 2025-06-30 | 0001789769-25-000081 | EDGAR | 58K words |
| 2025-05-13 | 2025-03-31 | 0001789769-25-000051 | EDGAR | 57K words |
| 2024-11-13 | 2024-09-30 | 0001789769-24-000103 | EDGAR | 60K words |
| 2024-08-13 | 2024-06-30 | 0001789769-24-000086 | EDGAR | 61K words |
| 2024-05-10 | 2024-03-31 | 0001789769-24-000059 | EDGAR | 60K words |
| 2023-11-13 | 2023-09-30 | 0001789769-23-000091 | EDGAR | 65K words |
| 2023-08-14 | 2023-06-30 | 0001789769-23-000085 | EDGAR | 64K words |
| 2023-05-11 | 2023-03-31 | 0001789769-23-000069 | EDGAR | 62K words |
| 2022-11-14 | 2022-09-30 | 0001789769-22-000098 | EDGAR | 62K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-16 | 0001789769-26-000064 | EDGAR | — |
| 2026-08-13 | 0001789769-26-000055 | EDGAR | 2K words |
| 2026-04-03 | 0001789769-26-000024 | EDGAR | 1K words |
| 2026-03-27 | 0001789769-26-000018 | EDGAR | 2K words |
| 2026-01-06 | 0001789769-26-000004 | EDGAR | 1K words |
| 2025-11-13 | 0001789769-25-000092 | EDGAR | 2K words |
| 2025-08-13 | 0001789769-25-000079 | EDGAR | 2K words |
| 2025-07-31 | 0001789769-25-000074 | EDGAR | 1K words |
| 2025-05-28 | 0001789769-25-000062 | EDGAR | 1K words |
| 2025-05-27 | 0001789769-25-000059 | EDGAR | 1K words |
98 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001789769 |
| Ticker | TIL |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | NY |
| Website | https://www.instilbio.com |
| Listed | 2021-03-19 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TIL (~200 tokens, structured JSON with cryptographic provenance)